Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation
Marcelo Kugelmas(University of Colorado Health), Gregory T. Everson(ColdQuanta, Inc., DBA Infleqtion (United States)), David A. Young(Newcastle University), Tracy Steinberg(University of Colorado Anschutz Medical Campus), Thomas H. Bak(University of Edinburgh), Purnima Spiegelman(University of Colorado Anschutz Medical Campus), Igal Kam(University of Colorado Denver), James F. Trotter(Baylor Scott & White Health), Michael J. Osgood(University of Colorado Health), Michael Wachs(NYU Langone Health)
Cited by 142
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonlinear Models for Repeated Measurement Data
|Journal of the American Statistical Association|1997|1.2k
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
|Proceedings of the National Academy of Sciences|1997|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
|Proceedings of the National Academy of Sciences|1992|831